Search

everythinglearnresearchcommunity

for

Search:↓

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Type I interferons play a key role in the development of various skin diseases.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Regulatory T cells are essential for normal and improved wound healing in mice.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Using neurohormones to control keratin can lead to new skin disease treatments.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Many patients on new leukemia drugs had mild to moderate skin reactions.